Tubervac – Serum International Institute
Indication and Usage –
- Tubervac (Bacille Calmette-Guerin Vaccine I.P.)is a live freeze-dried vaccine indicated for active immunization against disease caused by Mycobacterium tuberculosis.
- Tubervac is approved for use in infants at birth.
Dosage and Administration –
- Tubervac is administered by intradermal injection
- The vaccine should be administered in the dose of:
- A single 0.1 ml, Intradermal for Infants under one year of age
- A single 0.1 ml, Intradermal for children over one year of age till five years.
Contraindications –
- Tubervac is contraindicated in hypogamma-globulinemia, congenital immunodeficiency, sarcoidosis, leukaemia.
- In chronic eczema or other dermatological disease, the vaccine can be given in a healthy area of the skin.
- Keloid and lipoid reactions may also occur at the site of injection and such children should not be revaccinated.
Adverse reactions –
- Following BCG vaccination, 2-3 weeks later a papule develops at the site of vaccination and increases slowly in size to diameter of 4-8 mm in 5 weeks.
- It then subsides or breaks into a shallow ulcer covered with a crust, healing occurs spontaneously in 6-12 weeks leaving a permanent, tiny round scar 2-10 mm in diameter.
Drug interactions and other interactions –
- Tubervac may be routinely given to any child exposed early to the risk of contact with disease (tuberculosis).
- There is no indication to vaccinate women during pregnancy. Breast feeding can continue despite vaccination with BCG vaccine.
As a general rule, during pregnancy and breast feeding, it is always recommended to ask your doctor’s advice before using a medicinal product.
